Novel Oral AntiCoagulants and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Novel Oral AntiCoagulants (NOAC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Oral AntiCoagulants (NOAC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Oral AntiCoagulants (NOAC) Overall Market Size
2.1 Global Novel Oral AntiCoagulants (NOAC) Market Size: 2022 VS 2029
2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Novel Oral AntiCoagulants (NOAC) Sales: 2018-2029
3 Company Landscape
3.1 Top Novel Oral AntiCoagulants (NOAC) Players in Global Market
3.2 Top Global Novel Oral AntiCoagulants (NOAC) Companies Ranked by Revenue
3.3 Global Novel Oral AntiCoagulants (NOAC) Revenue by Companies
3.4 Global Novel Oral AntiCoagulants (NOAC) Sales by Companies
3.5 Global Novel Oral AntiCoagulants (NOAC) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Novel Oral AntiCoagulants (NOAC) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Players in Global Market
3.8.1 List of Global Tier 1 Novel Oral AntiCoagulants (NOAC) Companies
3.8.2 List of Global Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Market Size Markets, 2022 & 2029
4.1.2 Direct Thrombin Inhibitors
4.1.3 Direct Factor Xa Inhibitors
4.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
4.2.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2023
4.2.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2024-2029
4.2.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
4.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
4.3.1 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales, 2018-2023
4.3.2 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales, 2024-2029
4.3.3 By Type - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
4.4 By Type - Global Novel Oral AntiCoagulants (NOAC) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Market Size, 2022 & 2029
5.1.2 Deep Vein Thrombosis (DVT)
5.1.3 Pulmonary Embolism
5.1.4 Acute Coronary Syndrome
5.1.5 Hemodialysis
5.1.6 Others
5.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
5.2.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2023
5.2.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2024-2029
5.2.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
5.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
5.3.1 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales, 2018-2023
5.3.2 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales, 2024-2029
5.3.3 By Application - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
5.4 By Application - Global Novel Oral AntiCoagulants (NOAC) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Market Size, 2022 & 2029
6.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue & Forecasts
6.2.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2023
6.2.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue, 2024-2029
6.2.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
6.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales & Forecasts
6.3.1 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales, 2018-2023
6.3.2 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales, 2024-2029
6.3.3 By Region - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029
6.4.2 By Country - North America Novel Oral AntiCoagulants (NOAC) Sales, 2018-2029
6.4.3 US Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.4.4 Canada Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.4.5 Mexico Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029
6.5.2 By Country - Europe Novel Oral AntiCoagulants (NOAC) Sales, 2018-2029
6.5.3 Germany Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.4 France Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.5 U.K. Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.6 Italy Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.7 Russia Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.8 Nordic Countries Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.5.9 Benelux Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029
6.6.2 By Region - Asia Novel Oral AntiCoagulants (NOAC) Sales, 2018-2029
6.6.3 China Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.6.4 Japan Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.6.5 South Korea Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.6.6 Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.6.7 India Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029
6.7.2 By Country - South America Novel Oral AntiCoagulants (NOAC) Sales, 2018-2029
6.7.3 Brazil Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.7.4 Argentina Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales, 2018-2029
6.8.3 Turkey Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.8.4 Israel Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.8.5 Saudi Arabia Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
6.8.6 UAE Novel Oral AntiCoagulants (NOAC) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.1.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.2.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.4.4 Sanofi Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Daiichi Sankyo
7.5.1 Daiichi Sankyo Company Summary
7.5.2 Daiichi Sankyo Business Overview
7.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.5.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.5.5 Daiichi Sankyo Key News & Latest Developments
7.6 Armatheon
7.6.1 Armatheon Company Summary
7.6.2 Armatheon Business Overview
7.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.6.4 Armatheon Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.6.5 Armatheon Key News & Latest Developments
7.7 Aspen
7.7.1 Aspen Company Summary
7.7.2 Aspen Business Overview
7.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.7.4 Aspen Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.7.5 Aspen Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.8.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.9.4 Bayer Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 Cellceutix
7.10.1 Cellceutix Company Summary
7.10.2 Cellceutix Business Overview
7.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.10.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.10.5 Cellceutix Key News & Latest Developments
7.11 Cosmo Pharmaceuticals
7.11.1 Cosmo Pharmaceuticals Company Summary
7.11.2 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Business Overview
7.11.3 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.11.4 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.11.5 Cosmo Pharmaceuticals Key News & Latest Developments
7.12 CSL Behring
7.12.1 CSL Behring Company Summary
7.12.2 CSL Behring Novel Oral AntiCoagulants (NOAC) Business Overview
7.12.3 CSL Behring Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.12.4 CSL Behring Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.12.5 CSL Behring Key News & Latest Developments
7.13 Eisai
7.13.1 Eisai Company Summary
7.13.2 Eisai Novel Oral AntiCoagulants (NOAC) Business Overview
7.13.3 Eisai Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.13.4 Eisai Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.13.5 Eisai Key News & Latest Developments
7.14 GSK
7.14.1 GSK Company Summary
7.14.2 GSK Business Overview
7.14.3 GSK Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.14.4 GSK Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.14.5 GSK Key News & Latest Developments
7.15 Marathon Pharmaceuticals
7.15.1 Marathon Pharmaceuticals Company Summary
7.15.2 Marathon Pharmaceuticals Business Overview
7.15.3 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.15.4 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.15.5 Marathon Pharmaceuticals Key News & Latest Developments
7.16 Ockham Biotech
7.16.1 Ockham Biotech Company Summary
7.16.2 Ockham Biotech Business Overview
7.16.3 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.16.4 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.16.5 Ockham Biotech Key News & Latest Developments
7.17 Perosphere
7.17.1 Perosphere Company Summary
7.17.2 Perosphere Business Overview
7.17.3 Perosphere Novel Oral AntiCoagulants (NOAC) Major Product Offerings
7.17.4 Perosphere Novel Oral AntiCoagulants (NOAC) Sales and Revenue in Global (2018-2023)
7.17.5 Perosphere Key News & Latest Developments
8 Global Novel Oral AntiCoagulants (NOAC) Production Capacity, Analysis
8.1 Global Novel Oral AntiCoagulants (NOAC) Production Capacity, 2018-2029
8.2 Novel Oral AntiCoagulants (NOAC) Production Capacity of Key Manufacturers in Global Market
8.3 Global Novel Oral AntiCoagulants (NOAC) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Novel Oral AntiCoagulants (NOAC) Supply Chain Analysis
10.1 Novel Oral AntiCoagulants (NOAC) Industry Value Chain
10.2 Novel Oral AntiCoagulants (NOAC) Upstream Market
10.3 Novel Oral AntiCoagulants (NOAC) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Novel Oral AntiCoagulants (NOAC) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Novel Oral AntiCoagulants (NOAC) in Global Market
Table 2. Top Novel Oral AntiCoagulants (NOAC) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Novel Oral AntiCoagulants (NOAC) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Companies, 2018-2023
Table 5. Global Novel Oral AntiCoagulants (NOAC) Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Novel Oral AntiCoagulants (NOAC) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Novel Oral AntiCoagulants (NOAC) Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Novel Oral AntiCoagulants (NOAC) Product Type
Table 9. List of Global Tier 1 Novel Oral AntiCoagulants (NOAC) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Oral AntiCoagulants (NOAC) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2018-2023
Table 15. By Type - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2024-2029
Table 16. By Application ? Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2018-2023
Table 20. By Application - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2024-2029
Table 21. By Region ? Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2018-2023
Table 25. By Region - Global Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), 2024-2029
Table 26. By Country - North America Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales, (K Pcs), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 48. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 52. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 56. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 60. Sanofi Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 64. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. Armatheon Company Summary
Table 67. Armatheon Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 68. Armatheon Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Armatheon Key News & Latest Developments
Table 70. Aspen Company Summary
Table 71. Aspen Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 72. Aspen Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Aspen Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 76. AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 80. Bayer Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Bayer Key News & Latest Developments
Table 82. Cellceutix Company Summary
Table 83. Cellceutix Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 84. Cellceutix Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Cellceutix Key News & Latest Developments
Table 86. Cosmo Pharmaceuticals Company Summary
Table 87. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 88. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Cosmo Pharmaceuticals Key News & Latest Developments
Table 90. CSL Behring Company Summary
Table 91. CSL Behring Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 92. CSL Behring Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. CSL Behring Key News & Latest Developments
Table 94. Eisai Company Summary
Table 95. Eisai Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 96. Eisai Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Eisai Key News & Latest Developments
Table 98. GSK Company Summary
Table 99. GSK Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 100. GSK Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. GSK Key News & Latest Developments
Table 102. Marathon Pharmaceuticals Company Summary
Table 103. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 104. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Marathon Pharmaceuticals Key News & Latest Developments
Table 106. Ockham Biotech Company Summary
Table 107. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 108. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Ockham Biotech Key News & Latest Developments
Table 110. Perosphere Company Summary
Table 111. Perosphere Novel Oral AntiCoagulants (NOAC) Product Offerings
Table 112. Perosphere Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Perosphere Key News & Latest Developments
Table 114. Novel Oral AntiCoagulants (NOAC) Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 115. Global Novel Oral AntiCoagulants (NOAC) Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Novel Oral AntiCoagulants (NOAC) Production by Region, 2018-2023 (K Pcs)
Table 117. Global Novel Oral AntiCoagulants (NOAC) Production by Region, 2024-2029 (K Pcs)
Table 118. Novel Oral AntiCoagulants (NOAC) Market Opportunities & Trends in Global Market
Table 119. Novel Oral AntiCoagulants (NOAC) Market Drivers in Global Market
Table 120. Novel Oral AntiCoagulants (NOAC) Market Restraints in Global Market
Table 121. Novel Oral AntiCoagulants (NOAC) Raw Materials
Table 122. Novel Oral AntiCoagulants (NOAC) Raw Materials Suppliers in Global Market
Table 123. Typical Novel Oral AntiCoagulants (NOAC) Downstream
Table 124. Novel Oral AntiCoagulants (NOAC) Downstream Clients in Global Market
Table 125. Novel Oral AntiCoagulants (NOAC) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Novel Oral AntiCoagulants (NOAC) Segment by Type in 2022
Figure 2. Novel Oral AntiCoagulants (NOAC) Segment by Application in 2022
Figure 3. Global Novel Oral AntiCoagulants (NOAC) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Oral AntiCoagulants (NOAC) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Novel Oral AntiCoagulants (NOAC) Revenue, 2018-2029 (US$, Mn)
Figure 7. Novel Oral AntiCoagulants (NOAC) Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Novel Oral AntiCoagulants (NOAC) Revenue in 2022
Figure 9. By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 12. By Type - Global Novel Oral AntiCoagulants (NOAC) Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 16. By Application - Global Novel Oral AntiCoagulants (NOAC) Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 21. By Country - North America Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 23. US Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 28. Germany Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 29. France Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 37. China Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 41. India Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 44. Brazil Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share, 2018-2029
Figure 48. Turkey Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Novel Oral AntiCoagulants (NOAC) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Novel Oral AntiCoagulants (NOAC) Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Novel Oral AntiCoagulants (NOAC) by Region, 2022 VS 2029
Figure 54. Novel Oral AntiCoagulants (NOAC) Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
